Yujie Zhao, MD, PhD
Areas of Expertise:
Head and Neck
Phase I clinical trials
Novel therapeutics for head and neck cancer
Education and Training:
MD - Beijing Medical University (Center of Health Science, Peking University), Beijing, China (1994)
PhD – Rutgers University/University of Medicine and Dentistry of New Jersey, Piscataway, NJ (2004)
Saint Barnabas Medical Center, New Jersey Medical School, Livingston, NJ
American Board of Internal Medicine
Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ
- Phase I study of at-101 (R-(-)-gossypol) in combination with paclitaxel (P) and carboplatin (C) in solid tumors including castrate-resistant prostate cancer (CRPC) : 2011 Genitourinary Cancers Symposium. Journal of clinical oncology 2011; 29(7 Suppl.):169 .
- Vandetanib in the management of thyroid cancer. International journal of targeted therapies in cancer 2012; September:44-48 .